Endocrine Abstracts

Introduction: Bardet-Biedl Syndrome (BBS) is an autosomal recessive disease and one of the most common causes of syndromic obesity. An excessive weight usually appears at an early age and affects almost 90% of patients. Mutations in BBS genes have been found to disrupt the function of the cilia, leading to disturbances of transduction satiety and hunger signals in hypothalamus and increased adipogenesis in the fat tissue.Methods: We present a case series...

Background: FGF21 is a critical metabolic regulator with beneficial effects on lipid and glucose metabolism. FGF21 is produced primarily by the liver and stimulates fatty acids oxidation, which prevents hepatic triglycerides accumulation and nonalcoholic fatty liver disease (NALFD). FGF21also increases insulin sensitivity and glucose uptake in adipose tissue. Paradoxically FGF21 is elevated in insulin resistance states e.g. NALFD, obesity and type 2 diabetes. It is not determi...

Thyroid hormones (TH) are key regulators of basal metabolic rate and body weight. They increase resting energy expenditure by increased synthesis of uncoupling protein-1 (UCP-1) in brown adipocytes which stimulates energy dissipation as a heat. TH also increase appetite by central adrenergic stimulation. Body weight change is a key symptom of thyroid dysfunction especially the weight gain observed in patients treated for hyperthyroidism AIM: To compare the influence of differe...